Frequency News and Research

RSS

First quad-channel, 16-bit ADC for medical imaging applications

Texas Instruments Incorporated today introduced the first quad-channel, 16-bit analog-to-digital converter (ADC) for medical imaging applications, such as magnetic resonance imaging (MRI).

23 May 2011

Travel, hunting, and venison consumption linked to prion diseases

Researchers from the Centers for Disease Control and Prevention have examined the potential for human exposure to prion diseases, looking at hunting, venison consumption, and travel to areas in which prion diseases have been reported in animals.

23 May 2011

Phase 3 open-label study of RELISTOR presented at American Pain Society meeting

Salix Pharmaceuticals, Ltd. today announced findings from two analyses of a Phase 3 open-label study of RELISTOR (methylnaltrexone bromide) presented at the 30th Annual Scientific Meeting of the American Pain Society. The meeting is being held in Austin, TX, on May 19-21, 2011.

21 May 2011

Antibodies produced in space less effective than those produced on terra firma

The trip to Mars just got a little more difficult now that French researchers have discovered that antibodies used to fight off disease might become seriously compromised during long-term space flight. In a new report published online in the FASEB Journal, the scientists show that antibodies produced in space are less effective than those produced on terra firma.

21 May 2011

Study examines long-term GI complications in childhood cancer survivors

Individuals who are treated for cancer during childhood have a significantly higher risk of developing gastrointestinal complications - from mild to severe - later in life, according to a study led by the University of California, San Francisco. The findings underscore the need for childhood cancer survivors and their physicians to be aware of these risk factors to ensure patients' ongoing health care needs are met.

21 May 2011

Gen-Probe seeks FDA regulatory clearance for PANTHER fully automated and integrated molecular testing system

Gen-Probe Incorporated announced today that the Company has filed a 510(k) application with the US Food and Drug Administration for its PANTHER system, a fully automated and integrated molecular testing system designed with the flexibility to handle a wide range of testing needs.

20 May 2011

ViroPharma commences VP 20621 Phase 2 study for prevention of recurrent Clostridium difficile infection

ViroPharma Incorporated today announced initiation of a Phase 2 dose-ranging clinical study to evaluate the safety, tolerability, and efficacy of VP 20621 for prevention of recurrence of Clostridium difficile infection (CDI) in adults previously treated for CDI.

20 May 2011

Positive results from Astellas Pharma's mirabegron phase III trial in overactive bladder

Astellas Pharma US, Inc., U.S. subsidiary of Astellas Pharma Inc., today announced the results of a pivotal phase III clinical trial for mirabegron, the first of a new class of compounds under development for the treatment of overactive bladder (OAB), which show mirabegron significantly improves key OAB symptoms – urinary incontinence and frequency of micturition compared with placebo.

18 May 2011

New bronchial thermoplasty long-term safety data in asthma presented at ATS annual meeting

Boston Scientific Corporation today announced long-term safety data from the Research in Severe Asthma (RISA) Trial, which demonstrated the maintenance of stable lung function and the absence of clinical complications over a five-year period in patients with severe refractory asthma treated with its Alair Bronchial Thermoplasty System.

17 May 2011

Calypso System can precisely deliver radiation in post-prostatectomy patients

Calypso Medical Technologies, Inc., developer of GPS for the Body® technology used for the precise tracking of cancerous tumors during radiation therapy, is exhibiting at the American Urological Association Annual Meeting (booth 4337) and will discuss recent clinical findings suggesting that the Calypso® System can be used to more precisely deliver radiation in post-prostatectomy patients.

16 May 2011

AgenoLAB acquires Roche´s RTCA Cardio Instrument

AgenoLAB, the Stuttgart-based service provider, is the first company in Germany to expand its service offering with the latest cell analysis technology from Roche. The company will use the RTCA Cardio Instrument to complement their analytical service portfolio for drug development.

13 May 2011

Neuroscientists document deliberate control of touch sensations in human working memory

Neuroscientists of the Charité - Universitätsmedizin Berlin have now been able for the first time to document deliberate control of touch sensations in human working memory. It has been shown that the human brain can remember several touch sensations at the same time and consciously retrieve the touch if concentration is focused on these touches.

12 May 2011

Visual perception and attention can be changed by passive stimulation

What was previously known from animal studies has thus for the first time been demonstrated for human individuals too. "The findings open new perspectives in the intervention and treatment of visual perceptual disorders, because the changes can be induced quite simply" said Dr. Christian Beste of the RUB Institute of Cognitive Neuroscience.

12 May 2011

Injecting botox in 'trigger points' of pericraneal and neck muscles reduces migraine frequency

Scientists at the University of Granada have confirmed that injecting a local anesthetic or botulinum toxin (botox) into certain points named "trigger points" of the pericraneal and neck muscles reduce migraine frequency among migraine sufferers. University of Granada researchers have identified the location of these trigger points -which activation results in migraine- and their relationship with the duration and severity of this condition.

11 May 2011

Adherence to disease-modifying drugs is low in patients with multiple sclerosis

Disease-modifying drugs (DMDs) are injected medications used to slow the progression of multiple sclerosis, and have been shown to reduce the frequency and severity of relapses. But according to a new study led by St. Michael's Hospital and the Institute for Clinical Evaluative Sciences, adherence to all DMDs is low, with less than half of patients, or 44 per cent, continually adherent after two years.

11 May 2011

U.K. parliamentary committee report says U.N. response to Pakistan floods was 'patchy'

The U.N.'s response to severe flooding in Pakistan was "patchy," according to a report from the U.K.'s International Development Committee, which also said leadership and humanitarian coordination since the flooding started has been poor, AlertNet reports. As of February, about $1.2 billion of the U.N.'s $1.9 billion appeal had been received, according to the report, Reuters writes.

11 May 2011

ASA survey shows more than 90% of respondents experience anesthesia drug shortage

The American Society of Anesthesiologists today announced the findings from its nationwide Drug Shortages Survey. Results showed that more than 90 percent of anesthesiologist respondents are currently experiencing a shortage of at least one anesthetic.

10 May 2011

Abbott, Sucampo present lubiprostone phase 3 trial data in Japanese CIC at DDW 2011

Sucampo Pharmaceuticals, Inc. and Abbott today reported data from a phase 3 clinical efficacy trial in 124 Japanese chronic idiopathic constipation patients as well as from a phase 3 long-term safety trial in an additional 209 Japanese CIC patients.

10 May 2011

PTSD occurs with significant frequency in civilian patients after traumatic event involving physical injury

Although most commonly associated with military combat, post-traumatic stress disorder (PTSD) can occur in civilians, too - and with consequences that are just as serious, according to a new review article in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS). PTSD is a type of anxiety disorder that occurs after a person experiences a traumatic event involving physical injury, and occurs in 20 to 51 percent of patients with an orthopaedic injury.

9 May 2011

Boston Scientific launches Expect Endoscopic Ultrasound Aspiration Needle

Boston Scientific Corporation today announced the U.S. and international launch of its Expect™ Endoscopic Ultrasound Aspiration Needle, used for acquiring tissue samples for diagnosing and staging malignancies in organs adjacent to the gastrointestinal tract. The Expect Needle received FDA clearance and CE Mark approval earlier this year and is being marketed in the U.S., Europe and other international markets.

9 May 2011

Frequency News and Research

First quad-channel, 16-bit ADC for medical imaging applications

Travel, hunting, and venison consumption linked to prion diseases

Phase 3 open-label study of RELISTOR presented at American Pain Society meeting

Antibodies produced in space less effective than those produced on terra firma

Study examines long-term GI complications in childhood cancer survivors

Gen-Probe seeks FDA regulatory clearance for PANTHER fully automated and integrated molecular testing system

ViroPharma commences VP 20621 Phase 2 study for prevention of recurrent Clostridium difficile infection

Positive results from Astellas Pharma's mirabegron phase III trial in overactive bladder

New bronchial thermoplasty long-term safety data in asthma presented at ATS annual meeting

Calypso System can precisely deliver radiation in post-prostatectomy patients

AgenoLAB acquires Roche´s RTCA Cardio Instrument

Neuroscientists document deliberate control of touch sensations in human working memory

Visual perception and attention can be changed by passive stimulation

Injecting botox in 'trigger points' of pericraneal and neck muscles reduces migraine frequency

Adherence to disease-modifying drugs is low in patients with multiple sclerosis

U.K. parliamentary committee report says U.N. response to Pakistan floods was 'patchy'

ASA survey shows more than 90% of respondents experience anesthesia drug shortage

Abbott, Sucampo present lubiprostone phase 3 trial data in Japanese CIC at DDW 2011

PTSD occurs with significant frequency in civilian patients after traumatic event involving physical injury

Boston Scientific launches Expect Endoscopic Ultrasound Aspiration Needle

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News